Development of an Automated PD-L1 Immunohistochemistry (IHC) Assay for Non–Small Cell Lung Cancer

por Phillips, Therese, Simmons, Pauline, Inzunza, Hector D., Cogswell, John, Novotny, James, Taylor, Clive, Zhang, Xiaoling
Publicado 2015

Programmed death-ligand 1 (PD-L1) expression in various tumor types

por Grosso, Joseph, Inzunza, David, Wu, Qiuyan, Simon, Jason, Singh, Parul, Zhang, Xiaoling, Phillips, Therese, Simmons, Pauline, Cogswell, John
Publicado 2013

Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma

por Phillips, Therese, Millett, Molly M., Zhang, Xiaoling, Jansson, Malinka, Cleveland, Rachel, Simmons, Pauline, Cherryholmes, Gregory, Carnahan, Josette, William, Josette, Spaulding, Betsy, Satnick, Ilana R., Inzunza, H. David, Taylor, Clive, Cogswell, John, Novotny, James, Oroudjev, Emin, Winther, Henrik
Publicado 2018

Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab

por Callahan, Margaret K, Horak, Christine E, Curran, Michael A, Hollman, Travis, Schaer, David A, Yuan, Jianda, Lesokhin, Alexander M, Kitano, Shigehisa, Hong, Quan, Ariyan, Charlotte E, Busam, Klaus J, Feely, William, Jure-Kunkel, Maria, Grosso, Joseph, Simon, Jason S, Korman, Alan J, Wigginton, Jon M, Gupta, Ashok K, Zhang, Xiaoling, Phillips, Therese, Simmons, Pauline, Sznol, Mario, Wolchok, Jedd D
Publicado 2013